Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | | RFA-CA-25-002 | Department of Health and Human Services National Institutes of Health | 10/3/25 | 12/16/24 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | | RFA-CA-25-003 | Department of Health and Human Services National Institutes of Health | 10/3/25 | 12/16/24 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) | | RFA-CA-25-007 | Department of Health and Human Services National Institutes of Health | 10/3/25 | 12/31/24 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | | RFA-CA-25-001 | Department of Health and Human Services National Institutes of Health | 10/3/25 | 12/16/24 |
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | | PA-24-141 | Department of Health and Human Services National Institutes of Health | 10/7/24 | 3/7/24 |